SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) | 107254-86-4 | sc-201542 sc-201542B sc-201542A | 10 mg 25 mg 50 mg | $109.00 $193.00 $317.00 | 7 | |
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) acts as a GPR35 modulator, exhibiting a unique ability to stabilize receptor conformation through hydrophobic interactions and hydrogen bonding. This compound influences intracellular calcium signaling pathways, promoting distinct cellular responses. Its structural features enable selective receptor engagement, while its dynamic solubility enhances bioavailability, allowing for effective modulation of GPR35 activity in various environments. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid serves as a GPR35 modulator, characterized by its ability to engage in specific electrostatic interactions with receptor sites, influencing downstream signaling cascades. Its unique structural configuration allows for selective binding, which alters receptor dynamics and enhances signal transduction efficiency. Additionally, the compound's amphiphilic nature facilitates membrane permeability, promoting effective cellular uptake and interaction with lipid bilayers, thereby impacting GPR35-mediated pathways. | ||||||
Rosmarinic Acid | 20283-92-5 | sc-202796 sc-202796A | 10 mg 50 mg | $58.00 $109.00 | 4 | |
Rosmarinic acid acts as a GPR35 modulator, exhibiting a distinctive ability to form hydrogen bonds with key amino acid residues within the receptor. This interaction stabilizes the receptor's active conformation, leading to enhanced signaling pathways. Its polyphenolic structure contributes to its antioxidant properties, influencing cellular redox states. Furthermore, the compound's solubility in various solvents aids in its bioavailability, facilitating its engagement with GPR35 in diverse biological contexts. | ||||||
D-Luciferin potassium salt | 115144-35-9 | sc-278918 | 50 mg | $122.00 | ||
D-Luciferin potassium salt serves as a GPR35 ligand, characterized by its unique bioluminescent properties that arise from its interaction with the receptor. This compound engages in specific hydrophobic interactions, promoting receptor activation and downstream signaling cascades. Its structural flexibility allows for rapid conformational changes, enhancing reaction kinetics. Additionally, the salt form improves solubility, facilitating effective receptor engagement in various environments. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast (M&B 22948) acts as a GPR35 modulator, distinguished by its ability to selectively bind to the receptor, influencing intracellular calcium signaling. Its unique molecular structure enables specific hydrogen bonding and hydrophobic interactions, which stabilize the receptor-ligand complex. The compound exhibits notable reaction kinetics, allowing for swift activation of downstream pathways. Furthermore, its lipophilic nature enhances membrane permeability, optimizing its interaction dynamics within cellular environments. | ||||||
Pamoic acid disodium salt | 6640-22-8 | sc-362777 | 25 g | $63.00 | ||
Pamoic acid disodium salt serves as a GPR35 modulator, characterized by its capacity to engage in unique electrostatic interactions with the receptor. This compound facilitates the activation of signaling cascades through distinct conformational changes in the receptor structure. Its dual ionic nature promotes solubility in aqueous environments, enhancing its bioavailability. Additionally, the compound's ability to form stable complexes with GPR35 underscores its potential for influencing various intracellular processes. | ||||||
Pamoic acid | 130-85-8 | sc-212523 | 100 g | $92.00 | ||
Pamoic acid serves as a GPR35 modulator, characterized by its capacity to engage in ionic and hydrogen bonding interactions with the receptor. This compound promotes receptor activation through a unique mechanism that alters the spatial arrangement of key amino acids, facilitating signal transduction. Its amphipathic nature enhances its interaction with lipid bilayers, optimizing its localization and efficacy in cellular environments. The compound's distinct binding dynamics further shape its influence on receptor-mediated pathways. | ||||||
Compound 10 | 123021-85-2 | sc-364688 sc-364688A | 5 mg 25 mg | $111.00 $432.00 | ||
Compound 10 acts as a GPR35 modulator, exhibiting a unique ability to stabilize receptor dimers through hydrophobic interactions. This compound initiates specific signaling pathways by inducing allosteric changes in the receptor's conformation. Its lipophilic characteristics enhance membrane permeability, allowing for efficient receptor engagement. Furthermore, Compound 10's selective binding affinity contributes to its distinct kinetic profile, influencing downstream cellular responses. | ||||||